Last year's most important US False Claims Act story for the medical device industry was the continued repercussions and questions from a 2016 US Supreme Court decision, Universal Health Services Inc. v. United States ex rel. Escobar. The case changed the rules on when a company could be held liable for a false claim.
That’s according to Jonathan Phillips, a partner with Gibson Dunn, who discussed the law firm's 2017 Year-End False Claims...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?